Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

287 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Aberrant Complement Activation Is Associated With Structural Brain Damage in Multiple Sclerosis.
Oechtering J, Schaedelin SA, Stein K, Maleska Maceski A, Melie-Garcia L, Benkert P, Cagol A, Leber S, Galbusera R, Ruberte E, Hu W, Qureshi F, Orleth A, Demuth L, Willemse E, Heijnen I, Regeniter A, Derfuss TJ, Fischer-Barnicol B, Achtnichts L, Mueller S, Hoepner R, Lalive PH, Bridel C, D'Souza M, Pot C, Du Pasquier RA, Gobbi C, Zecca C, Wiendl H, Lieb JM, Lamers C, Kappos L, Trendelenburg M, Leppert D, Granziera C, Kuhle J, Lünemann JD; and the Swiss MS Cohort Study. Oechtering J, et al. Among authors: gobbi c. Neurol Neuroimmunol Neuroinflamm. 2025 Mar;12(2):e200361. doi: 10.1212/NXI.0000000000200361. Epub 2025 Jan 3. Neurol Neuroimmunol Neuroinflamm. 2025. PMID: 39752618 Free PMC article.
Association of the Cervical Canal Area With Disability and Progression in People With Multiple Sclerosis.
Mongay-Ochoa N, Pareto D, Alberich M, Carbonell-Mirabent P, Valsasina P, Margoni M, Braga N, Vidal-Jordana A, Auger C, Tintore M, Meani A, Gobbi C, Zecca C, Barkhof F, Schoonheim MM, Strijbis EMM, Gallo A, Bisecco A, Ciccarelli O, De Angelis F, Yiannakas MC, Palace J, Matthews L, Gass A, Eisele P, Lukas C, Bellenberg B, Preziosa P, Montalban X, Rocca MA, Filippi M, Rovira À, Sastre-Garriga J; MAGNIMS study group (Magnetic Resonance Imaging in Multiple Sclerosis). Mongay-Ochoa N, et al. Among authors: gobbi c. Neurology. 2025 Jan 14;104(1):e210136. doi: 10.1212/WNL.0000000000210136. Epub 2024 Dec 12. Neurology. 2025. PMID: 39666921
TNFα-inhibitors cycling with golimumab as second drug in inflammatory arthritis patients: Data from the multicenter GO-REAL registry.
Isnardi CA, Civit De Garignani EE, García Ciccarelli A, Sanchez Alcover J, Strusberg I, Baravalle M, Castaños S, Morales L, Palombo M, Albiero E, Gobbi C, Garcia Salinas R, Magri S, Velozo E, Soriano ER, Vargas Caselles A, Palomino Romero LC, Paira S, Calvo R, Ortiz A, Gamba MJ, Perez Alamino R, Maldonado Ficco H, Citera G. Isnardi CA, et al. Among authors: gobbi c. Reumatol Clin (Engl Ed). 2024 Dec;20(10):539-546. doi: 10.1016/j.reumae.2024.11.008. Reumatol Clin (Engl Ed). 2024. PMID: 39617528 Free article.
A single-chain variable fragment-based bispecific T-cell activating antibody against CD117 enables T-cell mediated lysis of acute myeloid leukemia and hematopoietic stem and progenitor cells.
Volta L, Myburgh R, Hofstetter M, Koch C, Kiefer JD, Gobbi C, Manfredi F, Zimmermann K, Kaufmann P, Fazio S, Pellegrino C, Russkamp NF, Villars D, Matasci M, Maurer M, Mueller J, Schneiter F, Büschl P, Harrer N, Mock J, Balabanov S, Nombela-Arrieta C, Schroeder T, Neri D, Manz MG. Volta L, et al. Among authors: gobbi c. Hemasphere. 2024 Nov 19;8(11):e70055. doi: 10.1002/hem3.70055. eCollection 2024 Nov. Hemasphere. 2024. PMID: 39564539 Free PMC article.
Self-reports by persons with multiple sclerosis are an adequate surrogate for healthcare provider data on disease-modifying therapy and multiple sclerosis type.
Stanikić M, Braun J, Ajdacic-Gross V, Manjaly ZM, Yaldizli Ö, Ineichen BV, Kamm CP, Iaquinto S, Gobbi C, Zecca C, Calabrese P, von Wyl V; Swiss Multiple Sclerosis Registry. Stanikić M, et al. Among authors: gobbi c. Mult Scler Relat Disord. 2023 Oct 21;80:105097. doi: 10.1016/j.msard.2023.105097. Online ahead of print. Mult Scler Relat Disord. 2023. PMID: 39491413 Free article.
Serum Glial Fibrillary Acidic Protein and Neurofilament Light Chain Levels Reflect Different Mechanisms of Disease Progression under B-Cell Depleting Treatment in Multiple Sclerosis.
Benkert P, Maleska Maceski A, Schaedelin S, Oechtering J, Zadic A, Vilchez Gomez JF, Melie-Garcia L, Cagol A, Galbusera R, Subramaniam S, Lorscheider J, Galli E, Mueller J, Fischer-Barnicol B, Achtnichts L, Findling O, Lalive PH, Bridel C, Uginet M, Müller S, Pot C, Mathias A, Du Pasquier R, Salmen A, Hoepner R, Chan A, Disanto G, Zecca C, D'Souza M, Hemkens LG, Yaldizli Ö, Derfuss T, Roth P, Gobbi C, Brassat D, Tackenberg B, Pedotti R, Raposo C, Oksenberg J, Wiendl H, Berger K, Hermesdorf M, Piehl F, Conen D, Buser A, Kappos L, Khalil M, Granziera C, Abdelhak A, Leppert D, Willemse EAJ, Kuhle J; Swiss MS Cohort study (SMSC). Benkert P, et al. Among authors: gobbi c. Ann Neurol. 2024 Oct 16;97(1):104-15. doi: 10.1002/ana.27096. Online ahead of print. Ann Neurol. 2024. PMID: 39411917 Free PMC article.
Immune triggers preceding neuralgic amyotrophy.
Sparasci D, Schilg-Hafer L, Schreiner B, Scheidegger O, Peyer AK, Lascano AM, Vicino A, Décard BF, Tsouni P, Humm AM, Pianezzi E, Zezza G, Hundsberger T, Dietmann A, Jung HH, Kuntzer T, Wilder-Smith E, Martinetti-Lucchini G, Petrini O, Fontana S, Gowland P, Niederhauser C, Gobbi C, Ripellino P. Sparasci D, et al. Among authors: gobbi c. Eur J Neurol. 2024 Dec;31(12):e16462. doi: 10.1111/ene.16462. Epub 2024 Oct 4. Eur J Neurol. 2024. PMID: 39364568 Free PMC article.
287 results